This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Celtaxsys Inc.

Drug Names(s): CTX4430, EP-501, CTX-4430

Description: CTX-4430 is a small molecule inhibitor of Leukotriene A4 Hydrolase (LTA4H), the pivotal enzyme for synthesis of the potent pro-inflammatory molecule Leukotriene B4 (LTB4). It has both high oral uptake and potent inhibition of LTA4H across several rodent and non-rodent species.

Deal Structure: Celtaxsys and Estrellita
In January 2012, Celtaxsys acquired CTX-4430 (formerly EP-501) from Estrellita Pharmaceuticals.

Acebilustat News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug